Due to the global Microsoft outage, a number of MBIE services are currently affected. Our teams are working closely with our technology providers to restore services as soon as possible. We appreciate your patience and understanding.
The research commercialisation funds, Commercialisation Partner Network Fund (CPN) and the PreSeed Accelerator Fund (PSAF), aim to strengthen the pathways, capability, and incentives needed to turn publicly funded research into commercial outcomes.
This Investment Plan outlines the policy context for the New Zealand Government’s investment in the Commercialisation Partner Network Fund (CPN) and the PreSeed Accelerator Fund (PSAF).
The 2027 Transition Research Fund ensures we continue to support great ideas from inception all the way through to the benefits they deliver for New Zealand. The fund supports high quality foundational and applied research across all disciplines that deliver impact aligned with national priorities.
We are inviting proposals for the Transition Research Fund 2027 Projects mechanism. The focus is on enabling bold, innovative research ideas through excellent research that are deemed likely to deliver meaningful benefits for New Zealand aligned with National Pillar Priorities.
The assessment of proposals for MBIE funding opportunities is performed by a considered selection of independent national and international Assessors from our virtual College of Assessors.
Informed by advice from the Prime Minister’s Science, Innovation and Technology Advisory Council, the Plan provides a 10-year direction for sustained investment toward opportunities with the greatest potential to drive economic growth and long-term prosperity and identifies research areas where New Zealand can lead, building on existing strengths that provide a competitive edge.